Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 20281 | Chinese Herbal Medicines | 8.8 | Q1 | Elsevier | 95.0% 6/112 Complementary and Alternative Medicine | 2227 | 252 |
| 20282 | Chinese Medicine (United Kingdom) | 9 | Q1 | Springer Nature | 95.0% 5/112 Complementary and Alternative Medicine | 5475 | 610 |
| 20283 | npj Vaccines | 11.6 | Q1 | Springer Nature | 95.0% 12/275 Pharmacology (medical) | 8418 | 723 |
| 20284 | Biomedicine and Pharmacotherapy | 12.8 | Q1 | Elsevier | 94.0% 19/321 Pharmacology | 80505 | 6306 |
| 20285 | Medicine in Drug Discovery | 10.8 | Q1 | Elsevier | 94.0% 16/275 Pharmacology (medical) | 1232 | 114 |
| 20286 | Journal of Cannabis Research | 7.7 | Q1 | Springer Nature | 93.0% 26/376 Health (social science) | 1391 | 181 |
| 20287 | Cellular and Molecular Life Sciences | 12.5 | Q1 | Springer Nature | 93.0% 22/321 Pharmacology | 23618 | 1886 |
| 20288 | International Journal of Neuropsychopharmacology | 9.7 | Q1 | Oxford University Press | 92.0% 44/580 Psychiatry and Mental Health | 3240 | 333 |
| 20289 | Natural Products and Bioprospecting | 8.5 | Q1 | Springer Nature | 91.0% 47/534 Plant Science | 1711 | 201 |
| 20290 | Expert Review of Vaccines | 11.2 | Q1 | Taylor & Francis | 91.0% 29/321 Pharmacology | 5031 | 450 |
| 20291 | Journal of Enzyme Inhibition and Medicinal Chemistry | 11.2 | Q1 | Taylor & Francis | 91.0% 28/321 Pharmacology | 7616 | 679 |
| 20292 | Vaccines | 9.9 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 91.0% 24/275 Pharmacology (medical) | 67553 | 6840 |
| 20293 | Disciplinary and Interdisciplinary Science Education Research | 5.2 | Q1 | Springer Nature | 89.0% 70/674 Social Sciences (miscellaneous) | 425 | 82 |
| 20294 | Frontiers in Pharmacology | 8.9 | Q1 | Frontiers Media S.A. | 89.0% 29/275 Pharmacology (medical) | 138968 | 15561 |
| 20295 | Addiction Biology | 7.8 | Q1 | John Wiley & Sons | 87.0% 73/580 Psychiatry and Mental Health | 4137 | 533 |
| 20296 | Drugs in Context | 5 | Q1 | Bioexcel Publishing LTD | 86.0% 94/668 General Medicine | 1186 | 236 |
| 20297 | Journal of Experimental Pharmacology | 8.2 | Q1 | Dove Medical Press | 86.0% 37/275 Pharmacology (medical) | 1371 | 168 |
| 20298 | Therapeutic Advances in Neurological Disorders | 8.5 | Q1 | SAGE | 86.0% 26/194 Neurology | 3022 | 355 |
| 20299 | Drug Design, Development and Therapy | 8.6 | Q1 | Dove Medical Press | 84.0% 51/321 Pharmacology | 11459 | 1329 |
| 20300 | Journal of Cardiovascular Pharmacology and Therapeutics | 6.6 | Q1 | SAGE | 80.0% 76/397 Cardiology and Cardiovascular Medicine | 975 | 147 |
| 20301 | Human Vaccines and Immunotherapeutics | 7.9 | Q1 | Taylor & Francis | 80.0% 62/321 Pharmacology | 16795 | 2113 |
| 20302 | CNS Neuroscience and Therapeutics | 6.4 | Q1 | John Wiley & Sons | 79.0% 121/580 Psychiatry and Mental Health | 8474 | 1329 |
| 20303 | Drug, Healthcare and Patient Safety | 5.2 | Q1 | Dove Medical Press | 78.0% 69/320 Health Policy | 382 | 73 |
| 20304 | Cardiovascular Therapeutics | 5.8 | Q1 | John Wiley & Sons | 76.0% 94/397 Cardiology and Cardiovascular Medicine | 1004 | 173 |
| 20305 | EJNMMI Radiopharmacy and Chemistry | 5.4 | Q1 | Springer Nature | 76.0% 82/346 Radiology, Nuclear Medicine and Imaging | 1040 | 194 |
| 20306 | Journal of Pharmacy and Pharmacognosy Research | 3.2 | Q1 | Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) | 75.0% 12/47 Pharmacy | 1171 | 371 |
| 20307 | Journal of Toxicology | 6.7 | Q2 | John Wiley & Sons | 74.0% 34/131 Toxicology | 780 | 116 |
| 20308 | Cancer Biology and Therapy | 6.2 | Q2 | Taylor & Francis | 74.0% 107/415 Oncology | 1937 | 313 |
| 20309 | Journal of Pharmacy and Pharmaceutical Sciences | 6.5 | Q2 | Frontiers Media S.A. | 73.0% 50/185 Pharmaceutical Science | 824 | 127 |
| 20310 | Medical Cannabis and Cannabinoids | 4.4 | Q2 | Karger | 73.0% 30/112 Complementary and Alternative Medicine | 287 | 65 |